Acquisition by Joseph Flanagan of 9061 shares of R1 RCM subject to Rule 16b-3

RCMDelisted Stock  USD 14.31  0.01  0.07%   
About 55% of R1 RCM's investor base is interested to short. The analysis of overall sentiment of trading R1 RCM Inc stock suggests that many investors are impartial at this time. R1 RCM's investing sentiment overview a quick insight into current market opportunities from investing in R1 RCM Inc. Many technical investors use R1 RCM Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by R1 Rcm Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
RCM insider trading alert for grant of common stock by Joseph Flanagan, the corporate stakeholder, on 7th of August 2023. This event was filed by R1 Rcm Inc with SEC on 2023-08-07. Statement of changes in beneficial ownership - SEC Form 4

R1 RCM Fundamental Analysis

We analyze R1 RCM's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of R1 RCM using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of R1 RCM based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

R1 RCM is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

R1 RCM Inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with R1 RCM stock to make a market-neutral strategy. Peer analysis of R1 RCM could also be used in its relative valuation, which is a method of valuing R1 RCM by comparing valuation metrics with similar companies.

Peers

R1 RCM Related Equities

CMAXCareMax   25.00   
0%
100.0%
HCATHealth Catalyst   4.04   
0%
16.0%
FORAForian   1.00   
0%
4.0%
HSTMHealthStream   1.99   
7.0%
0%
CERTCertara   2.02   
8.0%
0%
HQYHealthEquity   2.09   
8.0%
0%
EVHEvolent Health   2.26   
9.0%
0%
NRCNational Research   2.48   
9.0%
0%
PRVAPrivia Health   3.55   
14.0%
0%
SLPSimulations Plus   3.86   
15.0%
0%
DHDefinitive Healthcare   3.99   
15.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in RCM Stock

If you are still planning to invest in R1 RCM Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the R1 RCM's history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device